Abbott bags rights to Surmodics’ device, setting up showdown with Medtronic | FierceBiotech
Mar 2, 2018 @ 13:46

Abbott has secured the global rights to Surmodics’ drug-coated balloon. The company is paying $25 million upfront and committing to up to $67 million in development milestones to add the device to its vascular disease pipeline.

Sourced through from:

Leave a Reply